Detalhe da pesquisa
1.
Hybrid Capture-Based Tumor Sequencing and Copy Number Analysis to Confirm Origin of Metachronous Metastases in BRCA1-Mutant Cholangiocarcinoma Harboring a Novel YWHAZ-BRAF Fusion.
Oncologist
; 23(9): 998-1003, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29622700
2.
CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing.
PLoS Comput Biol
; 12(4): e1004873, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27100738
3.
NTRK3 kinase fusions in Spitz tumours.
J Pathol
; 240(3): 282-290, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27477320
4.
Design, Synthesis and Biological Evaluation of Novel Anticancer Amidinourea Analogues via Unexpected 1,3,5-Triazin-2-one Ring Opening.
ChemMedChem
; 19(3): e202300493, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38126619
5.
Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies.
Cell Death Dis
; 12(1): 64, 2021 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33431809
6.
Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses.
Cell Rep
; 29(3): 573-588.e7, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31618628
7.
Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation.
Cancer Cell
; 34(1): 56-68.e9, 2018 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29990501
8.
Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance.
Cancer Cell
; 29(6): 805-819, 2016 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27238082
9.
Comment on 'Testing for BRAF fusions in patients with advanced BRAF/NRAS/KIT wild-type melanomas permits to identify patients who could benefit of anti-MEK targeted therapy'.
J Clin Pathol
; 73(8): 524-525, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31852719
10.
Activating MET kinase rearrangements in melanoma and Spitz tumours.
Nat Commun
; 6: 7174, 2015 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-26013381
11.
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway.
Nat Genet
; 47(10): 1194-9, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26343386
12.
Kinase fusions are frequent in Spitz tumours and spitzoid melanomas.
Nat Commun
; 5: 3116, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24445538
13.
Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy.
Pigment Cell Melanoma Res
; 26(6): 845-51, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23890088
14.
Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance.
Cancer Cell
; 30(1): 183, 2016 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27479035
15.
Rac1 dynamics in the human opportunistic fungal pathogen Candida albicans.
PLoS One
; 5(10): e15400, 2010 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21060846
16.
Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion.
Pigment Cell Melanoma Res
; 28(5): 607-10, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26072686
17.
Melanoma BRAF fusions--letter.
Clin Cancer Res
; 20(24): 6631, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25512635
18.
In vitro and in vivo anti-melanoma effects of ciglitazone.
J Invest Dermatol
; 129(5): 1208-18, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19177142